Page 4 - Anuron Kumar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

2 Min Read BENGALURU (Reuters) - Indian shares gave up early gains to end sharply lower on Friday, as high-flying financial stocks sold off on the back of a broader rise in bond yields in the U.S. and Europe. A broker reacts while trading at his computer terminal at a stock brokerage firm in Mumbai, February 26, 2016. REUTERS/Shailesh Andrade/Files The blue-chip NSE Nifty 50 index fell 0.95% to close at 15,030.95, while the benchmark S&P BSE Sensex shed 0.95% to end at 50,792.08. Despite today’s losses, both indexes notched their second consecutive weekly gain. The Nifty and Sensex gained a...

2 Min Read BENGALURU (Reuters) - Indian shares rose on Tuesday as gains in high-flying financials eclipsed losses in energy stocks fuelled by a report that oil-marketing companies had been told by the government to not revise fuel prices for now. A broker trades on his computer terminal at a stock brokerage firm in Mumbai, India, January 20, 2016. REUTERS/Shailesh Andrade/Files By 0505 GMT, the blue-chip NSE Nifty 50 index climbed 0.71% to 15,061.90 and the benchmark S&P BSE Sensex gained 0.73% to 50,808.52, after rising as much as 1.1% earlier in the session. The Nifty Bank Index advanced 1....

Indian shares ended flat on Monday, as losses in top non-banking finance company HDFC countered gains in information technology and energy stocks, while top gold financing company Muthoot Finance fell after the death of its chairman.

Information Technology major Infosys Ltd and consulting and outsourcing services provider Accenture Plc said on Wednesday they would cover COVID-19 vaccination costs for their employees in India, as the country expands its massive vaccination drive. India's vaccination campaign ramped up on Monday, with people above the age of 60, and individuals 45 or older suffering from certain medical conditions, now eligible for shots. Vaccines administered at government health facilities will still be free, while private facilities cannot charge more than 250 rupees https://pib.gov.in/PressReleasePa...

By Anuron Kumar Mitra BENGALURU (Reuters) - India's Bharat Biotech is in the process of filing regulatory documents for approval of its COVID-19 vacci...